Immunoglobulin G4 [221-proline], anti-(human programmed cell death protein 1) (human monoclonal SG001 ?4-chain), disulfide with human monoclonal SG001 ?-chain, dimer
Metastatic Colorectal Cancer (CRC)
Hebei Medical University Fourth Hospitalmonoclonal_antibodyPhase 2/3Active
CCC
55/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 81/ 100
Competitive context
839 Active assets in the Metastatic Colorectal Cancer (CRC) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Desflurane Peter MacCallum Cancer Centre, Australia | Phase 4 | BBB |
MARBLE DUST James Varani | Phase 2/3 | BB |
PANITUMUMAB M.D. Anderson Cancer Center | Phase 3 | BB |
FLUOROURACILUM Washington University School of Medicine | Phase 4 | BB |
Cetuximab Shanghai Henlius Biotech | Phase 4 | BB |
View all 50 →
Same molecule, other indications
Immunoglobulin G4 [221-proline], anti-(human programmed cell death protein 1) (human monoclonal SG001 ?4-chain), disulfide with human monoclonal SG001 ?-chain, dimer is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →